Paroxysmal nocturnal hemoglobinuria: Where we stand
|
May 2023
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Paroxysmal nocturnal hemoglobinuria: Where are we going
|
May 2023
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Genomics of myelodysplastic/myeloproliferative neoplasm
|
May 2023
|
Seminars in Diagnostic Pathology
|
myelodysplastic syndromes (MDS)
|
Epidemiology and Pathogenesis of Myelodysplastic Syndrome
|
May 2023
|
The Cancer Journal
|
myelodysplastic syndromes (MDS)
|
Overview of the Management of Higher-Risk Myelodysplastic Syndromes
|
May 2023
|
The Cancer Journal
|
myelodysplastic syndromes (MDS)
|
Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age
|
May 2023
|
Blood Reviews
|
myelodysplastic syndromes (MDS)
|
The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances
|
May 2023
|
The Cancer Journal
|
myelodysplastic syndromes (MDS)
|
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes
|
May 2023
|
Current Treatment Options in Oncology
|
myelodysplastic syndromes (MDS)
|
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria
|
May 2023
|
International Journal of Molecular Sciences
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
|
May 2023
|
Journal of Clinical Oncology
|
myelodysplastic syndromes (MDS)
|